Amedisys (AMED) Tops Q2 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Operating expenses: 347.24M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.37, $0.28 better than the analyst estimate of $1.09. Revenue for the quarter came in at $552.97 million versus the consensus estimate of $568.18 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley cuts Cisco rating, sees pull-forward risk after strong run
- Portillo's Inc. (PTLO) Tops Q3 EPS by 3c; Offers Guidance
- MACOM Technology Solutions (MTSI) Tops Q4 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
